Lexicon Pharmaceuticals, Inc. (LXRX)
1.31
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
1.315
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Shareholders Equity (Quarterly) : 120.16M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novavax, Inc. | -156.67M |
| Viemed Healthcare, Inc. | 133.61M |
| Agenus, Inc. | -274.14M |
| Curis, Inc. | -14.69M |
| LadRx Corp. | -2.135M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 205.93M |
| Total Liabilities (Quarterly) | 85.77M |
| Debt to Equity Ratio | 0.5405 |
| Current Ratio | 5.641 |
| Net Debt Paydown Yield | 1.66% |